[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_16932 

# __Testing the antiviral efficacy of surfacewise 2 in liquid form using astm e1052 standard test method.__

## Articles mentionning the risk

* [Ikner_continuously_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_497.md)

## Mitigations of this risk

* [Ensure rigorous peer review and validation of test results before relying on them for decision-making.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_18881.md)

## Name of the risk

Unreliable test results may lead to the false assumption of effectiveness.

## People affected by this risk

* [And decision-makers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2788.md)
* [Research scientists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2912.md)

## Stakeholders who can mitigate this risk

* [And public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2693.md)

## Technologies linked to the risk

* [Advanced testing methods and equipment for accurate virus reduction measurements](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19324.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Healthcare infrastructure and technology adoption risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_45.md)

